Breakthrough-Therapy Designation - An FDA Perspective

被引：12
|
作者：
Corrigan-Curay, Jacqueline [1 ]
Mckee, Amy E. [1 ]
Stein, Peter [1 ]
机构：
[1] US FDA, Silver Spring, MD 20993 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2018年 / 378卷 / 15期
关键词：
D O I：
10.1056/NEJMc1801222
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1457 / 1458
页数：2
相关论文
共 50 条
  • [1] Rapastinel receives FDA breakthrough therapy designation
    不详
    [J]. NURSE PRACTITIONER, 2016, 41 (04): : 56 - 56
  • [2] Reflections on 10 years of the FDA's breakthrough therapy designation
    Mullard, Asher
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (04) : 252 - 253
  • [3] Physician Perceptions of the FDA's Breakthrough Therapy Designation: An Update
    Paquin, Ryan S.
    Boudewyns, Vanessa
    O'Donoghue, Amie C.
    Aikin, Kathryn J.
    [J]. ONCOLOGIST, 2022, 27 (01): : E85 - E88
  • [4] Reflections on 10 years of the FDA’s breakthrough therapy designation
    Asher Mullard
    [J]. Nature Reviews Drug Discovery, 2022, 21 : 252 - 253
  • [5] FDA Grants Breakthrough Therapy Designation to Magrolimab for MDS Treatment
    不详
    [J]. ONCOLOGY-NEW YORK, 2020, 34 (10): : 430 - 430
  • [6] FDA Grants Breakthrough Therapy Designation to Tiragolumab Atezolizumab Therapy for Metastatic NSCLC
    Slater, Hannah
    [J]. ONCOLOGY-NEW YORK, 2021, 35 (02): : 76 - 76
  • [7] Expediting Drug Development - The FDA's New "Breakthrough Therapy" Designation
    Sherman, Rachel E.
    Li, Jun
    Shapley, Stephanie
    Robb, Melissa
    Woodcock, Janet
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (20): : 1877 - 1880
  • [8] FDA breakthrough therapy designation for oncology products: The CBER experience.
    Singh, Harpreet
    Pazdur, Richard
    Xu, Lei
    Liu, Ke
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Two Meningococcal B vaccines receive FDA, Breakthrough Therapy' designation
    不详
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (06) : 1428 - 1429
  • [10] Pharmacists' Knowledge and Perceptions of FDA Approval Standards and the Breakthrough Therapy Designation
    Herink, Megan C.
    Johnston, Kirbee
    Breninger, Kristin
    Wu, Erin
    Irwin, Adriane N.
    [J]. PHARMACY, 2022, 10 (05)
12345